|
|
Dietary Combination For Prevention of Metastatic Renal Cell Carcinoma
|
5R01CA176691-05
|
$341,059
|
$341,059
|
LOKESHWAR, VINATA
|
AUGUSTA UNIVERSITY
|
|
|
(PQ3) Identifying Novel Pharmacologic Risk factors for Common Non-AIDS Defining Cancers in Individuals with Well-controlled HIV Infection
|
5R01CA206476-03
|
$706,386
|
$706,386
|
CHIAO, ELIZABETH
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Ruxolitinib for Preventing Breast Cancer in Women on Neuroleptics
|
5R01CA205594-02
|
$362,569
|
$362,569
|
LI, YI
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-12S1
|
$118,875
|
$5,944
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-12S2
|
$249,997
|
$12,500
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-12S3
|
$125,004
|
$6,250
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-12
|
$3,203,119
|
$160,156
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Translational Research in Breast Cancer (SPORE)
|
5P50CA186784-05
|
$2,251,410
|
$135,085
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Aspirin and Cancer Prevention in Lynch Syndrome: From Cell to Population Data
|
5U01CA187956-05
|
$510,193
|
$510,193
|
GOEL, AJAY
|
BAYLOR RESEARCH INSTITUTE
|
|
|
Reducing risk of Anthracycline-related heart failure after childhood cancer
|
5R01CA196854-04
|
$604,525
|
$604,525
|
ARMENIAN, SARO
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
|
Cancer Center Support Grant
|
2P30CA033572-35
|
$2,543,187
|
$50,864
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
|
Cancer Center Support Grant
|
3P30CA033572-34S3
|
$865,000
|
$17,300
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
|
Cancer Center Support Grant
|
3P30CA033572-35S1
|
$43,750
|
$875
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
|
Protective role of Honokiol in preventing c-Met-induced post-transplantation cancer
|
1R01CA222355-01
|
$411,068
|
$411,068
|
PAL, SOUMITRO
|
BOSTON CHILDREN'S HOSPITAL
|
|
|
The VITamin D and OmegA-3 TriaL (VITAL)
|
5R01CA138962-10
|
$3,474,603
|
$3,474,603
|
MANSON, JOANN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
The Effects of Vitamin D on Mammographic Density and Breast Tissue
|
5R01CA178263-05
|
$512,511
|
$512,511
|
REXRODE, KATHRYN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Dietary and Hormonal Determinants of Cancer in Women
|
5P01CA087969-19
|
$2,402,014
|
$480,403
|
STAMPFER, MEIR
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Calcium and Colorectal Cancer: Gene-Environment Interactions and Molecular Pathways
|
5K07CA188126-04
|
$144,000
|
$144,000
|
ZHANG, XUEHONG
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Novel Molecular Biomarkers and Therapeutics for Colorectal Cancer
|
1R50CA211119-01A1
|
$154,101
|
$154,101
|
FINK, STEPHEN
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Clinical Oncology Research Program (CORP)
|
2K12CA076917-21
|
$945,630
|
$94,563
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Case Comprehensive Cancer Center Support Grant
|
2P30CA043703-28
|
$5,637,954
|
$338,277
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-28S1
|
$249,965
|
$14,998
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Contribution of Gynecologic and Breast Cancer Biospecimens from African American women to HCMI
|
3P30CA043703-28S2
|
$48,000
|
$2,880
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Case GI SPORE
|
5P50CA150964-07
|
$2,500,000
|
$450,000
|
MARKOWITZ, SANFORD
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Targeting 15-Prostaglandin Dehydrogenase (15-PGDH) in Cancer Risk, Prevention, and Treatment
|
5R35CA197442-02
|
$951,000
|
$951,000
|
MARKOWITZ, SANFORD
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Regulatory Support for Cancer Prevention Agent Development
|
261201800017C
|
$2,653,402
|
$2,653,402
|
-, -
|
CCS ASSOCIATES, INC.
|
|
|
Technical Information Research Resources for Cancer Preventive Agent Development
|
261201800030C
|
$2,219,906
|
$2,219,906
|
-, -
|
CCS ASSOCIATES, INC.
|
|
|
Increased chemoprevention by a mixture of three phytochemicals in prostate cancer
|
5R03CA208221-02
|
$77,704
|
$77,704
|
WANG, PIWEN
|
CHARLES R. DREW UNIVERSITY OF MED & SCI
|
|
|
Understanding the niche of minimal residual disease leukemia cells
|
2R01CA172896-06
|
$402,563
|
$402,563
|
KIM, YONG-MI
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
|
Pre-IND development of CBT-15 monoclonal antibody therapy against renal cell cancer
|
1R44CA228895-01A1
|
$298,835
|
$298,835
|
SUREBAN, SRIPATHI
|
COARE HOLDINGS, INC.
|
|
|
Rice Bran Microbial Metabolism for Colon Chemoprevention
|
5R01CA201112-03
|
$351,223
|
$351,223
|
RYAN, ELIZABETH
|
COLORADO STATE UNIVERSITY
|
|
|
Increasing breast cancer chemoprevention in the primary care setting
|
3R01CA177995-05S1
|
$167,842
|
$167,842
|
CREW, KATHERINE
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Increasing breast cancer chemoprevention in the primary care setting
|
5R01CA177995-05
|
$532,782
|
$532,782
|
CREW, KATHERINE
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Improving Esophageal Adenocarcinoma Prevention, Screening and Treatment
|
7R01CA140574-10
|
$306,765
|
$76,691
|
HUR, CHIN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Cancer Center Support Grant
|
3P30CA013696-44S1
|
$120,000
|
$3,600
|
SCHWARTZ, GARY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Cancer Center Support Grant
|
3P30CA013696-44S2
|
$60,000
|
$1,800
|
SCHWARTZ, GARY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Cancer Center Support Grant - PDXNet Supplement
|
3P30CA013696-44S3
|
$126,563
|
$3,797
|
SCHWARTZ, GARY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Cancer Center Support Grant
|
3P30CA013696-44S4
|
$191,726
|
$5,752
|
SCHWARTZ, GARY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Cancer Center Support Grant
|
3P30CA013696-44S5
|
$237,191
|
$7,116
|
SCHWARTZ, GARY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Cancer Center Support Grant
|
3P30CA013696-44S6
|
$246,815
|
$7,404
|
SCHWARTZ, GARY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Cancer Center Support Grant
|
3P30CA013696-44S7
|
$224,982
|
$6,749
|
SCHWARTZ, GARY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Cancer Center Support Grant
|
3P30CA013696-44S8
|
$126,563
|
$3,797
|
SCHWARTZ, GARY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Cancer Center Support Grant
|
3P30CA013696-44S9
|
$250,000
|
$7,500
|
SCHWARTZ, GARY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Cancer Center Support Grant
|
5P30CA013696-44
|
$3,972,720
|
$119,182
|
SCHWARTZ, GARY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Genomics and Mechanisms of Esophageal Carcinogenesis
|
5R01CA208711-03
|
$366,000
|
$109,800
|
SEPULVEDA, ANTONIA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
The Role of the Microenvironment in Barretts Esophagus
|
3U54CA163004-07S1
|
$93,257
|
$24,247
|
WANG, TIMOTHY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
The Role of the Microenvironment in Barretts Esophagus
|
5U54CA163004-07
|
$1,085,045
|
$282,112
|
WANG, TIMOTHY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
A Prospective, Randomized Study to Compare Effects of Ulipristal Acetate with a Combined Oral Contraceptive on Breast Epithelial Cell Proliferation.
|
5R01CA200795-03
|
$406,451
|
$406,451
|
WESTHOFF, CAROLYN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-53S1
|
$445,796
|
$13,374
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-53S2
|
$59,495
|
$1,785
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Total relevant funding to Chemoprevention for this search: $101,789,902
|
